AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.35 and traded as high as $9.33. AIkido Pharma shares last traded at $7.58, with a volume of 2,016,839 shares traded.
AIkido Pharma Trading Down 3.7 %
The firm’s fifty day moving average price is $3.37 and its 200-day moving average price is $2.35. The company has a market cap of $41.58 million, a P/E ratio of -1.95 and a beta of 0.93.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- What is the S&P 500 and How It is Distinct from Other Indexes
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- Health Care Stocks Explained: Why You Might Want to Invest
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- How to Use Stock Screeners to Find Stocks
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
